Pfizer/BioNTech Say Three Shots Generate Strong Immune Response in Kids Under 5

Office of the Secretary of DefenVials of the COVID-19 vaccine are seen at Walter Reed National Military Medical Center, Bethesda, Md., Dec. 14, 2020. | Lisa Ferdinando

Pfizer and BioNTech said on Monday that three doses of their COVID-19 vaccine produced a strong immune response in children under the age of five in their clinical trial. Pfizer and BioNTech said they found that the vaccine was up …

Read more

Pfizer and BioNTech Says COVID-19 Booster Increases Protection Against Omicron for Kids 5-11

Fourth EstateHand holding a vaccine vial

Pfizer and BioNech announced on Thursday that a third booster vaccine increases immune defenses against COVID-19 in children ages 5 to 11, particularly against the Omicron variant. Pfizer and BioNTech said that blood serum analysis of a few pediatric participants …

Read more

Drugmakers Sanofi and GSK Seek Authorization for Their COVID-19 Vaccine

Drugmakers Sanofi and GSK announced on Feb. 23 that they are planning to seek approval from regulators for their COVID-19 vaccine. The companies said data from clinical trials showed that their vaccine works either as a primary vaccine or as …

Read more

New Zealand Grants Provisional Approval for Novavax COVID-19 Vaccine for Adults

New Zealand medicines regulator Medsafe on Feb. 4 granted provisional approval for the Novavax COVID-19 vaccine for people aged 18 years and over. The provisional approval does not mean that New Zealand has committed to use Novavax as it is …

Read more

UK Approves Novavax COVID-19 Vaccine for People Aged Over 18

The United Kingdom on Feb. 3 approved the Novavax COVID-19 vaccine for people over the age of 18. The Medicines and Healthcare products Regulatory Agency (MHRA) granted the vaccine regulatory approval, following a “rigorous review of safety, quality, and effectiveness,” …

Read more

Pfizer-BioNTech Asks U.S. FDA to Authorize COVID-19 Vaccine for Kids Under Five

Pfizer and BioNTech on Feb. 1 has requested the United States Food and Drug Administration (FDA) to expand the use of its COVID-19 vaccine to children aged six months to four years. The companies said they applied for the emergency …

Read more

Novavax Seeks U.S. FDA Emergency Use Authorization for Its COVID-19 Vaccine

Novavax has formally submitted a request for the United States Food and Drug Administration (FDA) to grant emergency use authorization for its COVID-19 vaccine for adults. The vaccine, taken in two doses 21 days apart, demonstrated an overall efficacy of …

Read more

Moderna Starts Clinical Trial on Omicron-Specific COVID-19 Booster in Adults

Moderna has started a clinical trial to test its COVID-19 vaccine booster shot specifically targeted against the highly contagious Omicron variant, the company announced on Jan. 26. Moderna said that its Phase 2 study, which is its first trial using …

Read more

Pfizer CEO Announces Omicron Vaccine to be Ready in March

Pfizer is aiming to have a COVID-19 vaccine that specifically targets the Omicron variant to be ready in March, the chief executive officer (CEO) said on Jan. 10. Pfizer CEO Albert Bourla told CNBC’s “Squawk Box” that his company has …

Read more

European Commission Signs COVID-19 Vaccine Deal with Valneva

The European Commission has approved on Nov. 10 a deal with French vaccine company Valneva to supply up to 60 million doses of its COVID-19 vaccine candidate over the next two years. Under the deal, nearly 27 million doses of …

Read more